Creo Medical Group PLC (AIM: CREO)

Creo Medical Group Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	3	3	13.1	43.53	45.09	81.05
Short-Term Investments	15.5	15.5	-	-	-	-
Cash & Short-Term Investments	18.5	18.5	13.1	43.53	45.09	81.05
Cash Growth	41.22%	41.22%	-69.91%	-3.46%	-44.36%	81.77%
Accounts Receivable	6.4	6.4	5	3.88	4.24	-
Other Receivables	4.2	4.2	5.2	4.88	3.1	4.08
Receivables	10.6	10.6	10.2	8.76	7.33	4.08
Inventory	8.1	8.1	9.3	8.5	6.81	0.73
Prepaid Expenses	0.7	0.7	1.1	0.37	0.23	0.24
Total Current Assets	37.9	37.9	33.7	61.17	59.47	86.09
Property, Plant & Equipment	8.5	8.5	9.7	8.6	3.38	1.3
Long-Term Investments	2.7	2.7	2.6	1.73	0.5	-
Goodwill	19.1	19.1	19.6	18.56	18.26	-
Other Intangible Assets	6.8	6.8	7.8	8.33	9.78	0.75
Long-Term Deferred Tax Assets	1.1	1.1	1.5	1.71	0.47	-
Long-Term Deferred Charges	0.3	0.3	0.2	0.36	0.49	0.12
Other Long-Term Assets	0.2	0.2	0.1	0.15	0.11	0.01
Total Assets	76.6	76.6	75.2	100.61	92.46	88.26
Accounts Payable	2.5	2.5	4.3	3.54	2.46	0.92
Accrued Expenses	2.5	2.5	4.1	5.18	4.19	3.92
Short-Term Debt	2	2	3.8	3.32	3.34	-
Current Portion of Long-Term Debt	0.5	0.5	1.2	1.39	1.85	-
Current Portion of Leases	0.6	0.6	0.6	0.67	0.62	0.17
Other Current Liabilities	1.8	1.8	3.4	5.63	5.56	0.04
Total Current Liabilities	9.9	9.9	17.4	19.74	18.03	5.06
Long-Term Debt	4.4	4.4	4.9	3.79	5.16	0.36
Long-Term Leases	0.8	0.8	1.2	1.39	1.39	0.19
Long-Term Deferred Tax Liabilities	1.4	1.4	2	1.79	2	-
Other Long-Term Liabilities	0.3	0.3	0.4	0.59	3.09	-
Total Liabilities	16.8	16.8	25.9	27.29	29.66	5.6
Common Stock	0.4	0.4	0.2	0.18	0.16	0.15
Additional Paid-In Capital	180.9	180.9	149.5	149.45	115.26	115.11
Retained Earnings	-144.4	-144.4	-122.7	-95.76	-71.17	-50.85
Comprensive Income & Other	22.9	22.9	22.3	19.45	18.55	18.25
Total Common Equity	59.8	59.8	49.3	73.32	62.81	82.66
Shareholders' Equity	59.8	59.8	49.3	73.32	62.81	82.66
Total Liabilities & Equity	76.6	76.6	75.2	100.61	92.46	88.26
Total Debt	8.3	8.3	11.7	10.56	12.36	0.72
Net Cash (Debt)	10.2	10.2	1.4	32.98	32.74	80.33
Net Cash Growth	628.57%	628.57%	-95.75%	0.74%	-59.25%	81.93%
Net Cash Per Share	0.03	0.03	0.01	0.20	0.21	0.66
Filing Date Shares Outstanding	351.25	351.25	181.38	178.1	157.89	150.38
Total Common Shares Outstanding	351.25	351.25	181.38	178.1	157.89	150.38
Working Capital	28	28	16.3	41.43	41.44	81.04
Book Value Per Share	0.17	0.17	0.27	0.41	0.40	0.55
Tangible Book Value	33.9	33.9	21.9	46.42	34.77	81.92
Tangible Book Value Per Share	0.10	0.10	0.12	0.26	0.22	0.54
Land	4.6	4.6	4.6	4.51	-	-
Machinery	6.2	6.2	6	5.11	3.78	1.52
Construction In Progress	0.1	0.1	1.4	0.15	0.03	0.24
Leasehold Improvements	2.6	2.6	0.9	0.74	0.7	0.57

Source: S&P Capital IQ. Standard template. Financial Sources.